Academic literature on the topic 'Anti-arthritis'

Create a spot-on reference in APA, MLA, Chicago, Harvard, and other styles

Select a source type:

Consult the lists of relevant articles, books, theses, conference reports, and other scholarly sources on the topic 'Anti-arthritis.'

Next to every source in the list of references, there is an 'Add to bibliography' button. Press on it, and we will generate automatically the bibliographic reference to the chosen work in the citation style you need: APA, MLA, Harvard, Chicago, Vancouver, etc.

You can also download the full text of the academic publication as pdf and read online its abstract whenever available in the metadata.

Journal articles on the topic "Anti-arthritis"

1

Chaabo, Khaldoun, and Bruce Kirkham. "Rheumatoid Arthritis — Anti-TNF." International Immunopharmacology 27, no. 2 (2015): 180–84. http://dx.doi.org/10.1016/j.intimp.2015.04.051.

Full text
APA, Harvard, Vancouver, ISO, and other styles
2

KAKUMANU, PRASANTHI, ERIC S. SOBEL, SONALI NARAIN, et al. "Citrulline Dependence of Anti-Cyclic Citrullinated Peptide Antibodies in Systemic Lupus Erythematosus as a Marker of Deforming/Erosive Arthritis." Journal of Rheumatology 36, no. 12 (2009): 2682–90. http://dx.doi.org/10.3899/jrheum.090338.

Full text
Abstract:
Objective.Anti-cyclic citrullinated peptide (CCP) antibodies are a serological marker for rheumatoid arthritis (RA); up to 10%–15% of patients with systemic lupus erythematosus (SLE) are also positive. While anti-CCP in RA is citrulline-dependent, anti-CCP in some other diseases is citrulline-independent and reacts with both CCP and the unmodified (arginine-containing) cyclic arginine peptide (CAP). We investigated the citrulline dependence of anti-CCP and its significance in the arthritis of SLE.Methods.IgG anti-CCP was compared by ELISA to anti-CAP in sera from patients with SLE (n = 335) an
APA, Harvard, Vancouver, ISO, and other styles
3

Inanc, N., E. Dalkılıc, S. Kamalı, et al. "Anti-CCP antibodies in rheumatoid arthritis and psoriatic arthritis." Clinical Rheumatology 26, no. 1 (2006): 17–23. http://dx.doi.org/10.1007/s10067-006-0214-5.

Full text
APA, Harvard, Vancouver, ISO, and other styles
4

Stewart, I., and J. C. Ridway. "Anti-Ro positive rheumatoid arthritis." Annals of the Rheumatic Diseases 45, no. 1 (1986): 86–87. http://dx.doi.org/10.1136/ard.45.1.86-b.

Full text
APA, Harvard, Vancouver, ISO, and other styles
5

HERZOG, C. "MONOCLONAL ANTI-CD4 IN ARTHRITIS." Lancet 330, no. 8573 (1987): 1461–62. http://dx.doi.org/10.1016/s0140-6736(87)91158-5.

Full text
APA, Harvard, Vancouver, ISO, and other styles
6

Larkin, Marilynn. "Nutraceuticals' anti-arthritis benefits “exaggerated”." Lancet 355, no. 9208 (2000): 993. http://dx.doi.org/10.1016/s0140-6736(05)74734-6.

Full text
APA, Harvard, Vancouver, ISO, and other styles
7

Mergaert, Aisha M., Mandar Bawadekar, Thai Q. Nguyen, et al. "Reduced Anti-Histone Antibodies and Increased Risk of Rheumatoid Arthritis Associated with a Single Nucleotide Polymorphism in PADI4 in North Americans." International Journal of Molecular Sciences 20, no. 12 (2019): 3093. http://dx.doi.org/10.3390/ijms20123093.

Full text
Abstract:
Autoantibodies against citrullinated proteins are a hallmark of rheumatoid arthritis, a destructive inflammatory arthritis. Peptidylarginine deiminase 4 (PAD4) has been hypothesized to contribute to rheumatoid arthritis by citrullinating histones to induce neutrophil extracellular traps (NETs), which display citrullinated proteins that are targeted by autoantibodies to drive inflammation and arthritis. Consistent with this theory, PAD4-deficient mice have reduced NETs, autoantibodies, and arthritis. However, PAD4′s role in human rheumatoid arthritis is less clear. Here, we determine if single
APA, Harvard, Vancouver, ISO, and other styles
8

MOHAMMED, KHULOOD, JANET POPE, NICOLE LE RICHE, et al. "Association of Severe Inflammatory Polyarthritis in Primary Sjögren’s Syndrome: Clinical, Serologic, and HLA Analysis." Journal of Rheumatology 36, no. 9 (2009): 1937–42. http://dx.doi.org/10.3899/jrheum.080234.

Full text
Abstract:
Objective.To evaluate the clinical, serologic, and MHC class II antigen characteristics of a group of patients with primary Sjögren’s syndrome (SS) and severe arthritis.Methods.A case-control study comparing 35 patients with primary SS: 17 with inflammatory arthritis, 18 without arthritis.Results.All patients fulfilled criteria for primary SS. There were no demographic or clinical features other than inflammatory arthritis, often erosive, that distinguished patients with arthritis from those without. All patients had anti-Ro/SSA autoantibodies, most had anti-La/SSB autoantibodies, and a high p
APA, Harvard, Vancouver, ISO, and other styles
9

De Vries, Charlotte, Alexandra Cîrciumaru, Linda Mathsson-Alm, et al. "Porphyromonas gingivalisassociates with the presence of anti-citrullinated protein antibodies, but not with the onset of arthritis: studies in an at-risk population." RMD Open 11, no. 1 (2025): e005111. https://doi.org/10.1136/rmdopen-2024-005111.

Full text
Abstract:
ObjectiveThe antibody response againstPorphyromonas gingivalis(Pg) is elevated in rheumatoid arthritis (RA), especially in patients with anti-citrullinated protein antibodies (ACPA). Here, we investigated whether antibodies against thePgvirulence factor arginine gingipain (Rgp) are associated with the RA-risk phase and development of arthritis.MethodsAt-risk individuals were included in a prospective study (Risk-RA) based on a positive anti-cyclic citrullinated peptide 2 (CCP2) antibody test, and having musculoskeletal complaints but no signs of arthritis. Study participants were followed for
APA, Harvard, Vancouver, ISO, and other styles
10

Dong, Baoqi, Wenqing Wu, Jingbao Chen, and Xiao-qin Chu. "The Anti-Arthritis Effect of Cinnamaldehyde on Adjuvant Arthritis Rats." International Journal of Pharmacology 18, no. 3 (2022): 551–61. http://dx.doi.org/10.3923/ijp.2022.551.561.

Full text
APA, Harvard, Vancouver, ISO, and other styles
More sources

Dissertations / Theses on the topic "Anti-arthritis"

1

Mohajane, Mamohale. "Dipeptides as potential anti-flammatory drugs for rheumatoid arthritis." Master's thesis, University of Cape Town, 2013. http://hdl.handle.net/11427/6340.

Full text
Abstract:
Includes abstract.<br>Includes bibliographical references.<br>The H⁺ and Cu²⁺ equilibria of four glycine peptides (glycyl-glycine, glycyl-L-leucine, glycyl-L-phenylalanine and glycyl-L-histidine) and four sarcosine peptides (sarcosylglycine, sarcosyl-L-leucine, sarcosyl-L-phenylalanine and sarcosyl-L-histidine) have been studied using glass electrode potentiometry and isothermal titration calorimetry at 25 °C and an ionic strength 0.15 M (NaCl). The terminal amine of the sarcosine peptides is more basic than the glycine analogues. The methyl group on the terminal amine (for sarcosine peptides)
APA, Harvard, Vancouver, ISO, and other styles
2

Podgorski, M. R. "Clinical and pathological significance of anti-lipocortin autoantibodies in rheumatoid arthritis." Thesis, University of Southampton, 1988. http://ethos.bl.uk/OrderDetails.do?uin=uk.bl.ethos.328478.

Full text
APA, Harvard, Vancouver, ISO, and other styles
3

Cleaver, Catherine Sarah. "The role of interleukin-4 and interleukin-13 in the prevention of cartilage breakdown." Thesis, University of Newcastle Upon Tyne, 2000. http://ethos.bl.uk/OrderDetails.do?uin=uk.bl.ethos.327238.

Full text
APA, Harvard, Vancouver, ISO, and other styles
4

Mohamed, Ahmed A. "Redox studies on the anti-rheumatoid arthritis gold drugs : Auranofin and Solganol /." Fogler Library, University of Maine, 2000. http://www.library.umaine.edu/theses/pdf/MohamedAA2000.pdf.

Full text
APA, Harvard, Vancouver, ISO, and other styles
5

Dunagan, Fiona M. "Non-steroidal anti-inflammatory drugs : pharmacokinetics and clinical response in rheumatoid arthritis." Thesis, University of Glasgow, 1986. http://ethos.bl.uk/OrderDetails.do?uin=uk.bl.ethos.236497.

Full text
APA, Harvard, Vancouver, ISO, and other styles
6

Mercer, Louise. "Safety of long-term anti-TNF use, with respect to malignancy, in a national cohort of people with rheumatoid arthritis." Thesis, University of Manchester, 2013. https://www.research.manchester.ac.uk/portal/en/theses/safety-of-longterm-antitnf-use-with-respect-to-malignancy-in-a-national-cohort-of-people-with-rheumatoid-arthritis(be2ba2c3-a9a2-4a23-a3fb-c5688e990f93).html.

Full text
Abstract:
AimThe broad aim of this thesis was to explore the risk of malignancy in people with rheumatoid arthritis (RA), treated with anti-tumour necrosis factor (TNF) drugs.MethodsThis thesis used data from patients with RA registered with the British Society of Rheumatology Biologics Register-RA. The risk of cancer in biologic-naive patients treated with traditional disease modifying drugs (nbDMARD) was compared to that in the general population by calculating standardised incidence ratios (SIR). The influence of anti-TNF on cancer risk was then explored by comparing the risk in the anti-TNF cohort t
APA, Harvard, Vancouver, ISO, and other styles
7

Mullazehi, Mohammed. "Anti-Collagen Type II Autoantibodies in an Acute Phenotype of Early Rheumatoid Arthritis." Doctoral thesis, Uppsala universitet, Institutionen för onkologi, radiologi och klinisk immunologi, 2009. http://urn.kb.se/resolve?urn=urn:nbn:se:uu:diva-100483.

Full text
Abstract:
Rheumatoid arthritis (RA) is an autoimmune disease with systemic inflammatory features that primarily affects small peripheral joints. Type II collagen (CII), is the most abundant collagen type in joint cartilage. Antibodies against CII (anti-CII) are found in a subpopulation of RA patients. Anti-CII can form surface-bound immune complexes (IC) in inflamed joints, which might intensify joint inflammation and destruction. In this thesis I have studied the functional effects of surface-bound anti-CII–containing IC in vitro and correlated the results to clinical parameters. Anti-CII IC induced TN
APA, Harvard, Vancouver, ISO, and other styles
8

Phua, K. K. "The relationship between rheumatoid-factor and anti-strptococcal peptidoglycan antibody in rheumatoid arthritis." Thesis, University of Liverpool, 1985. http://ethos.bl.uk/OrderDetails.do?uin=uk.bl.ethos.370866.

Full text
APA, Harvard, Vancouver, ISO, and other styles
9

SILVA, JÚNIOR Auvani Antunes da. "Imunossensor baseado em grafeno-polissulfona para detecção da artrite reumatoide: antipeptídeo citrulinado." Universidade Federal de Pernambuco, 2016. https://repositorio.ufpe.br/handle/123456789/17776.

Full text
Abstract:
Submitted by Fabio Sobreira Campos da Costa (fabio.sobreira@ufpe.br) on 2016-09-01T12:21:37Z No. of bitstreams: 2 license_rdf: 1232 bytes, checksum: 66e71c371cc565284e70f40736c94386 (MD5) DISSETAÇAO_DEPOSITO.pdf: 1662534 bytes, checksum: 6bdb1ae293f1a65771c195438f64d3f0 (MD5)<br>Made available in DSpace on 2016-09-01T12:21:38Z (GMT). No. of bitstreams: 2 license_rdf: 1232 bytes, checksum: 66e71c371cc565284e70f40736c94386 (MD5) DISSETAÇAO_DEPOSITO.pdf: 1662534 bytes, checksum: 6bdb1ae293f1a65771c195438f64d3f0 (MD5) Previous issue date: 2016-03-09<br>CAPEs<br>A artrite reumatóide (AR) é uma do
APA, Harvard, Vancouver, ISO, and other styles
10

Hui, Kwun-ho. "The diagnostic and prognostic value of anti-CCP assay in the juvenile idiopathic arthritis (JIA)." Click to view the E-thesis via HKUTO, 2004. http://sunzi.lib.hku.hk/hkuto/record/B31971817.

Full text
APA, Harvard, Vancouver, ISO, and other styles
More sources

Books on the topic "Anti-arthritis"

1

1940-, Orme Michael, ed. Anti-rheumatic drugs. Pergamon Press, 1990.

Find full text
APA, Harvard, Vancouver, ISO, and other styles
2

Fabio, Anthony Di. The art of getting well!: Rheumatoid arthritis cured at last!! Rheumatoid Disease Foundation, 1988.

Find full text
APA, Harvard, Vancouver, ISO, and other styles
3

ed, Lewis Alan 1945, Ackerman Neil ed, Otterness Ivan ed, and Inflammation Research Association. International Conference, eds. New perspectives in anti-inflammatory therapies. Raven Press, 1988.

Find full text
APA, Harvard, Vancouver, ISO, and other styles
4

Porter, Suzanne. Suzanne Porter's anti arthritis diet: A sensible approach for a pain-free life. Marlin Publications, 1990.

Find full text
APA, Harvard, Vancouver, ISO, and other styles
5

Kandel, Joseph. The anti-arthritis diet: Increase mobility and reduce pain with this 28-day life-changing program. Primo Pub, 1998.

Find full text
APA, Harvard, Vancouver, ISO, and other styles
6

Research & Forecasts, Inc., ed. Arthritis and other chronic pain conditions: Problems associated with drug therapy. Research & Forecasts, 1985.

Find full text
APA, Harvard, Vancouver, ISO, and other styles
7

G, Lombardino J., ed. Nonsteroidal antiinflammatory drugs. Wiley, 1985.

Find full text
APA, Harvard, Vancouver, ISO, and other styles
8

European Congress of Rheumatology (11th 1987 Athens, Greece). Tenoxicam: Presentations to the XIth European Congress of Rheumatology, 1987. Edited by Cairns A. EULAR, 1988.

Find full text
APA, Harvard, Vancouver, ISO, and other styles
9

B, Sudderth David, ed. The anti-arthritis diet: Increase mobility and reduce pain with this 28-day life-changing program. Prima Health, 1998.

Find full text
APA, Harvard, Vancouver, ISO, and other styles
10

F, Willkens Robert, and Dahl Stephen L, eds. Therapeutic controversies in the rheumatic diseases. Grune & Stratton, 1987.

Find full text
APA, Harvard, Vancouver, ISO, and other styles
More sources

Book chapters on the topic "Anti-arthritis"

1

Saha, Kunal Kumar, Anik Barman, and Narayan Chandra Mandal. "Anti-Inflammatory and Anti-Arthritis Properties of Ganoderma." In Ganoderma. CRC Press, 2024. http://dx.doi.org/10.1201/9781003354789-9.

Full text
APA, Harvard, Vancouver, ISO, and other styles
2

Hassfeld, W., G. Steiner, W. Graninger, and J. S. Smolen. "Anti-RA33: A New Antinuclear Antibody in Rheumatoid Arthritis." In Rheumatoid Arthritis. Springer Berlin Heidelberg, 1992. http://dx.doi.org/10.1007/978-3-642-76189-8_21.

Full text
APA, Harvard, Vancouver, ISO, and other styles
3

Wang, Peng, Xuegang Luo, Chongxi Wang, Xinjia Wang, Guang Hu, and Tong-Cun Zhang. "Research Progress on the Anti-Rheumatoid Arthritis Drugs." In Proceedings of the 2012 International Conference on Applied Biotechnology (ICAB 2012). Springer Berlin Heidelberg, 2013. http://dx.doi.org/10.1007/978-3-642-37922-2_94.

Full text
APA, Harvard, Vancouver, ISO, and other styles
4

Ebringer, Alan. "Anti-Proteus Antibodies in Norwegian Rheumatoid Arthritis Patients Following a Lactovegetarian Diet." In Rheumatoid Arthritis and Proteus. Springer London, 2011. http://dx.doi.org/10.1007/978-0-85729-950-5_8.

Full text
APA, Harvard, Vancouver, ISO, and other styles
5

Bosch, X., J. Llena, J. Font, et al. "Anti-Granulocyte Perinuclear Antibodies but Not Anti-Neutrophil Cytoplasmic Antibodies (ANCA) in Rheumatoid Arthritis." In Advances in Experimental Medicine and Biology. Springer US, 1993. http://dx.doi.org/10.1007/978-1-4757-9182-2_64.

Full text
APA, Harvard, Vancouver, ISO, and other styles
6

Emmrich, F., G. Horneff, W. Becker, et al. "An Anti-CD4 Antibody for Treatment of Chronic Inflammatory Arthritis." In Drugs in Inflammation. Birkhäuser Basel, 1991. http://dx.doi.org/10.1007/978-3-0348-7405-2_22.

Full text
APA, Harvard, Vancouver, ISO, and other styles
7

Goldblatt, F., and D. A. Isenberg. "Anti-CD20Monoclonal Antibody in Rheumatoid Arthritis and Systemic Lupus Erythematosus." In Therapeutic Antibodies. Springer Berlin Heidelberg, 2008. http://dx.doi.org/10.1007/978-3-540-73259-4_8.

Full text
APA, Harvard, Vancouver, ISO, and other styles
8

Coremans, Ida E. M., Ernst C. Hagen, Fokko J. van der Woude, et al. "Anti-Lactoferrin Antibodies in Patients with Rheumatoid Arthritis with Vasculitis." In Advances in Experimental Medicine and Biology. Springer US, 1993. http://dx.doi.org/10.1007/978-1-4757-9182-2_60.

Full text
APA, Harvard, Vancouver, ISO, and other styles
9

Sundy, John S. "Nonsteroidal Anti-Inflammatory Drugs in the Treatment of Rheumatoid Arthritis." In Modern Therapeutics in Rheumatic Diseases. Humana Press, 2002. https://doi.org/10.1007/978-1-59259-239-5_3.

Full text
APA, Harvard, Vancouver, ISO, and other styles
10

Taylor, P. C., R. O. Williams, and R. N. Maini. "Anti-TNFα Therapy in Rheumatoid Arthritis - Current and Future Directions." In Current Directions in Autoimmunity. KARGER, 2000. http://dx.doi.org/10.1159/000060499.

Full text
APA, Harvard, Vancouver, ISO, and other styles

Conference papers on the topic "Anti-arthritis"

1

Li, Yan, Zibo Ouyang, Rui Li, and Shao Li. "Network analysis for anti-rheumatoid arthritis TCM prescriptions." In 2013 IEEE International Conference on Bioinformatics and Biomedicine (BIBM). IEEE, 2013. http://dx.doi.org/10.1109/bibm.2013.6732651.

Full text
APA, Harvard, Vancouver, ISO, and other styles
2

Zhan, Junping, and Guang Zheng. "Anti-rheumatoid Arthritis Mechanisms of Angelicae Pubescentis Radix." In 2019 IEEE International Conference on Bioinformatics and Biomedicine (BIBM). IEEE, 2019. http://dx.doi.org/10.1109/bibm47256.2019.8982935.

Full text
APA, Harvard, Vancouver, ISO, and other styles
3

Parchami, Ghazaee, Kateryna Marchenko-Tolsta, Novykova Larisa, and Mykola Hryshkov. "ANTI-INFLAMMATORY PROPERTIES OF PHYTOCONSTITUENTS IN MANAGING RHEUMATOID ARTHRITIS." In RICERCHE SCIENTIFICHE E METODI DELLA LORO REALIZZAZIONE: ESPERIENZA MONDIALE E REALTÀ DOMESTICHE. European Scientific Platform, 2024. http://dx.doi.org/10.36074/logos-26.04.2024.090.

Full text
APA, Harvard, Vancouver, ISO, and other styles
4

Kolarz, Bogdan, Magdalena Dryglewska, Marek Ciesla, and Maria Majdan. "THU0139 IS ADDING ANTI-CARP OR ANTI-PADI4 BENEFICIAL FOR DIAGNOSIS OF RHEUMATOID ARTHRITIS?" In Annual European Congress of Rheumatology, EULAR 2019, Madrid, 12–15 June 2019. BMJ Publishing Group Ltd and European League Against Rheumatism, 2019. http://dx.doi.org/10.1136/annrheumdis-2019-eular.2117.

Full text
APA, Harvard, Vancouver, ISO, and other styles
5

Regueiro, C., A. Montes, MD Boveda, et al. "FRI0040 Characterization of anti-carbamylated synovial protein antibodies (ANTI-CARPS) in rheumatoid arthritis patients." In Annual European Congress of Rheumatology, 14–17 June, 2017. BMJ Publishing Group Ltd and European League Against Rheumatism, 2017. http://dx.doi.org/10.1136/annrheumdis-2017-eular.4789.

Full text
APA, Harvard, Vancouver, ISO, and other styles
6

Nenasheva, NV, AS Trofimenko, IP Gontar, LA Maslakova, OA Rusanova, and OV Paramonova. "FRI0146 Anti-elastin and anti-elastase autoantibodies: potential clinical and diagnostic implications in rheumatoid arthritis." In Annual European Congress of Rheumatology, 14–17 June, 2017. BMJ Publishing Group Ltd and European League Against Rheumatism, 2017. http://dx.doi.org/10.1136/annrheumdis-2017-eular.2593.

Full text
APA, Harvard, Vancouver, ISO, and other styles
7

Carbone, Teresa, Carmela Esposito, Ornella Mercuro, et al. "SAT0645 ANTI-DFS70 AUTOANTIBODIES INDUCED BY ANTI-TNF THERAPY IN RHEUMATOID ARTHRITIS AND SPONDYLOARTHRITIS PATIENTS." In Annual European Congress of Rheumatology, EULAR 2019, Madrid, 12–15 June 2019. BMJ Publishing Group Ltd and European League Against Rheumatism, 2019. http://dx.doi.org/10.1136/annrheumdis-2019-eular.5636.

Full text
APA, Harvard, Vancouver, ISO, and other styles
8

Volkava, M., and A. Kundzer. "SAT0660 Clinical significance of anti-ra33 autoantybodies in rheumatoid arthritis." In Annual European Congress of Rheumatology, EULAR 2018, Amsterdam, 13–16 June 2018. BMJ Publishing Group Ltd and European League Against Rheumatism, 2018. http://dx.doi.org/10.1136/annrheumdis-2018-eular.6873.

Full text
APA, Harvard, Vancouver, ISO, and other styles
9

Ratanawatkul, P., J. J. Swigris, and J. J. Solomon. "Positive Anti-Cyclic Citrullinated Peptide (anti-CCP) May Not Be a Pre-Phenotype for Rheumatoid Arthritis." In American Thoracic Society 2021 International Conference, May 14-19, 2021 - San Diego, CA. American Thoracic Society, 2021. http://dx.doi.org/10.1164/ajrccm-conference.2021.203.1_meetingabstracts.a1794.

Full text
APA, Harvard, Vancouver, ISO, and other styles
10

Verhoeven, F., C. Prati, P. Totoson, R. Bordy, D. Wendling та C. Demougeot. "FRI0044 Non-steroidal anti-inflammatory drugs are more beneficial than anti-tnfα drugs on the radiographic damage in arthritis: a study in adjuvant induced arthritis". У Annual European Congress of Rheumatology, 14–17 June, 2017. BMJ Publishing Group Ltd and European League Against Rheumatism, 2017. http://dx.doi.org/10.1136/annrheumdis-2017-eular.2611.

Full text
APA, Harvard, Vancouver, ISO, and other styles

Reports on the topic "Anti-arthritis"

1

Koleva, Kalina, Stanislav Marchev, Rumen Nikolov, Mila Vlaskovska, and Slavina Surcheva. The Role of Diabetes on Experimental Arthritis: Analgesic, Anti-inflammatory and Adverse Effects of NSAID. "Prof. Marin Drinov" Publishing House of Bulgarian Academy of Sciences, 2020. http://dx.doi.org/10.7546/crabs.2020.09.14.

Full text
APA, Harvard, Vancouver, ISO, and other styles
2

Mamus, M. A., E. A. Tikhomirova, S. A. Bedina, S. S. Dotsenko, A. S. Trofimenko, and E. E. Mozgovaya. NEUTROPHIL EXTRACELLULAR TRAPS AND THEIR EVENTUAL ROLE IN THE ANTI-CITRULLINATED PROTEIN ANTIBODIES GENERATION IN RHEUMATOID ARTHRITIS. Планета, 2018. http://dx.doi.org/10.18411/978-5-907109-24-7-2018-xxxv-202-211.

Full text
APA, Harvard, Vancouver, ISO, and other styles
3

Aleksandrov, A. V., N. V. Nikitinа, N. V. Aleksandrova, I. А. Zborovskaya, and Y. A. Trubenko. PECULIARITIES OF DIAGNOSTICS OF DIASTOLIC FORM OF CARDIAC INSUFFICIENCY IN PATIENTS WITH ANTI-CCP POSITIVE RHEUMATOID ARTHRITIS. "PLANET", 2019. http://dx.doi.org/10.18411/978-5-907192-54-6-2019-xxxvi-12-18.

Full text
APA, Harvard, Vancouver, ISO, and other styles
4

Fan, Yihua, Xiaoyin Zhao, Xiaoxu He, and Huixin Chen. Efficacy and safety of Chinese herbal compound in the treatment of acute gouty arthritis: A protocol of a systematic review and meta-analysis. INPLASY - International Platform of Registered Systematic Review and Meta-analysis Protocols, 2022. http://dx.doi.org/10.37766/inplasy2022.4.0153.

Full text
Abstract:
Review question / Objective: To evaluate the efficacy and safety of Chinese herbal compound in the treatment of acute gouty arthritis. Eligibility criteria: 1.1.1 Literature type Randomized controlled trials of treating AGA with Chinese herbal compound alone, whether blind or not, was limited to Chinese literature and English literature.1.1.2 SubjectsThe time of onset, gender, and age of patients diagnosed with acute gouty arthritis were not restricted.1.1.3 Intervention measures The treatment group was treated with traditional Chinese medicine compound, which could be proprietary Chinese medi
APA, Harvard, Vancouver, ISO, and other styles
5

Fan, Yihua, Xiaoyin Zhao, Xiaoxu He, and Huixin Chen. Efficacy and safety of Chinese herbal compound in the treatment of acute gouty arthritis: A protocol of a systematic review and meta-analysis. INPLASY - International Platform of Registered Systematic Review and Meta-analysis Protocols, 2022. http://dx.doi.org/10.37766/inplasy2022.4.0153.

Full text
Abstract:
Review question / Objective: To evaluate the efficacy and safety of Chinese herbal compound in the treatment of acute gouty arthritis. Eligibility criteria: 1.1.1 Literature type Randomized controlled trials of treating AGA with Chinese herbal compound alone, whether blind or not, was limited to Chinese literature and English literature.1.1.2 SubjectsThe time of onset, gender, and age of patients diagnosed with acute gouty arthritis were not restricted.1.1.3 Intervention measures The treatment group was treated with traditional Chinese medicine compound, which could be proprietary Chinese medi
APA, Harvard, Vancouver, ISO, and other styles
6

Yang, Xiaochun, Yue Cai, Bin Xue, and Bo Zhang. Diagnostic value of anti-cyclic citrullinated peptide antibody combined with rheumatoid factor in rheumatoid arthritis in Asia: a meta-analysis. INPLASY - International Platform of Registered Systematic Review and Meta-analysis Protocols, 2021. http://dx.doi.org/10.37766/inplasy2021.8.0106.

Full text
APA, Harvard, Vancouver, ISO, and other styles
7

Xie, Sisi, Shu Li, Bilin Chen, Qing Zhu, Lichang Xu, and Fen Li. Serum anti-citrullinated protein antibodies and rheumatoid factor increase the risk of rheumatoid arthritis-associated interstitial lung disease: a meta-analysis. INPLASY - International Platform of Registered Systematic Review and Meta-analysis Protocols, 2021. http://dx.doi.org/10.37766/inplasy2021.4.0071.

Full text
APA, Harvard, Vancouver, ISO, and other styles
We offer discounts on all premium plans for authors whose works are included in thematic literature selections. Contact us to get a unique promo code!